as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹441.9
Change
+12.9 (3.01%)
Open
₹429.3
Prev. Close
₹429.0
Day High
₹444.2
Day Low
₹421.2
Volume Analysis
Traded
442,258
Delivered
327,771
Delivery %
74.11%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •High debt-to-equity ratio (1.09)
- •Low return on equity (8.38%)
Opportunities (2)
- •Strong 3-year EPS growth (24.4%)
- •Strong 3-year revenue growth (31.4%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹473.34 | ₹458.77 | ₹450.34 | ₹435.77 | ₹427.34 | ₹412.77 | ₹404.34 |
| Fibonacci | ₹458.77 | ₹449.98 | ₹444.56 | ₹435.77 | ₹426.98 | ₹421.56 | ₹412.77 |
| Camarilla | ₹448.23 | ₹446.12 | ₹444.01 | ₹435.77 | ₹439.79 | ₹437.68 | ₹435.58 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+10.39%
1 Week
+6.47%
1 Month
+1.79%
3 Months
-2.55%
6 Months
+7.58%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹211.1
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
8.85%
Net margin 7.76% × asset turnover 0.46x × equity multiplier 2.48x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹3,789 Cr
P/E (TTM)
24.2
ROE
8.38%
Book Value
₹177.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Trualt Bioenergy Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 58/100. The strongest factor is Growth (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.09); low return on equity (8.38%). Strong 3-year EPS growth (24.4%).
TopFund Score — Fundamentals Quality
58/100 — AverageData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is expected to give good quarter
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Promoters have pledged 36.8% of their holding.
- −Working capital days have increased from -31.2 days to 63.4 days
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Nirani Holdings bought 1,52,201 shares for Rs 6.69 crore, raising stake to 2.11%.
NHPL pledged 14 lakh TruAlt Bioenergy shares to Jio Credit on 22 Sept 2026.
NSE and BSE fined TruAlt for Reg 17(1) and 29 lapses; compliance restored after woman director appointment.
NHPL bought 50,000 TruAlt shares at Rs.424.64, raising stake to 1.93%.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 197 | 388 | 415 | 907 | 304 | 115 | 713 | 596 | 627 |
| Expenses + | 184 | 371 | 291 | 753 | 262 | 119 | 579 | 466 | 494 |
| Operating Profit | 14 | 17 | 125 | 154 | 42 | -5 | 134 | 129 | 133 |
| OPM % | 7.0% | 4.5% | 30.0% | 17.0% | 14.0% | -4.0% | 19.0% | 22.0% | 21.0% |
| Other Income + | 15 | 17 | 15 | 14 | 23 | 15 | 18 | 31 | 15 |
| Interest | 35 | 34 | 36 | 39 | 38 | 39 | 40 | 44 | 44 |
| Depreciation | 16 | 16 | 18 | 18 | 21 | 21 | 22 | 23 | 25 |
| Profit before tax | -22 | -16 | 86 | 111 | 6 | -49 | 90 | 94 | 78 |
| Tax % | 0.0% | 15.0% | 13.0% | -1.0% | 18.0% | -23.0% | 23.0% | 27.0% | 24.0% |
| Net Profit + | -22 | -19 | 75 | 112 | 5 | -38 | 69 | 69 | 59 |
| EPS in Rs | -3 | -3 | 11 | 16 | 1 | -4 | 8 | 8 | 7 |
| Raw PDF | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales + | 762 | 1,223 | 1,908 | 1,728 | 2,050 |
| Expenses + | 657 | 1,035 | 1,599 | 1,438 | 1,659 |
| Operating Profit | 105 | 188 | 309 | 290 | 392 |
| OPM % | 14.0% | 15.0% | 16.0% | 17.0% | 19.0% |
| Other Income + | 0 | 57 | 61 | 86 | 78 |
| Interest | 35 | 143 | 144 | 160 | 166 |
| Depreciation | 21 | 57 | 67 | 86 | 90 |
| Profit before tax | 49 | 45 | 159 | 130 | 213 |
| Tax % | 28.0% | 29.0% | 8.0% | 25.0% | — |
| Net Profit + | 35 | 32 | 147 | 97 | 159 |
| EPS in Rs | 6 | 5 | 21 | 11 | 18 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Reserves | 179 | 204 | 698 | 1,435 |
| Borrowings + | 1,150 | 1,685 | 1,557 | 1,652 |
| Other Liabilities + | 465 | 469 | 704 | 606 |
| Total Liabilities | 1,856 | 2,418 | 3,030 | 3,778 |
| Fixed Assets + | 1,302 | 1,427 | 1,826 | 2,185 |
| CWIP | 10 | 201 | 3 | 68 |
| Investments | 0 | 10 | 4 | 4 |
| Other Assets + | 545 | 780 | 1,197 | 1,521 |
| Total Assets | 1,856 | 2,418 | 3,030 | 3,778 |
| Equity Capital | 61 | 61 | 71 | 86 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 233 | 35 | 342 | -296 |
| Cash from Investing Activity + | -1,149 | -384 | -255 | -413 |
| Cash from Financing Activity + | 920 | 367 | 40 | 648 |
| Net Cash Flow | 5 | 19 | 126 | -62 |
| CFO/OP | 222 | 21 | 110 | -99 |
| Free Cash Flow | -42 | -321 | 82 | -806 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Public | 21.26% | 19.38% | 20.51% |
| Promoters | 70.55% | 70.55% | 70.55% |
| FII | 0.93% | 0.66% | 0.57% |
| DII | 7.28% | 9.4% | 8.36% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Trualt Bioenergy Limited (this stock) | 3,789 | 24.2 | 2.5 | 8.38% |
| Heritage Foods Ltd | 3,908 | 30.8 | 3.54 | 12.6% |
| Vst Industries Ltd | 3,474 | 56.5 | 13.95 | 24.9% |
| Kaveri Seed Co. Ltd. | 4,145 | 16.6 | 2.36 | 18.2% |
| Parag Milk Foods Ltd. | 3,378 | 25.1 | 2.66 | 12.1% |
| Dalmia Bharat Sug In Ltd | 3,312 | 16.2 | 1.02 | 7.3% |
| Adf Foods Limited | 2,984 | 30.8 | 5.22 | 17.7% |
Which Mutual Funds Hold Trualt Bioenergy Limited?
Frequently Asked Questions about Trualt Bioenergy Limited
Trualt Bioenergy Limited (TRUALT) closed at ₹441.9 on NSE on 25 September 2026, up 12.9 (3.01%) from the previous close.
Trualt Bioenergy Limited trades on the NSE (National Stock Exchange of India) under the symbol TRUALT.
Trualt Bioenergy Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 24.2.
Trualt Bioenergy Limited has a dividend yield of 0.0%.
Trualt Bioenergy Limited's 52-week high is ₹550.0 and its 52-week low is ₹310.0.
Trualt Bioenergy Limited has a market capitalisation of ₹3,789 crore.
Trualt Bioenergy Limited has a TopFund Quality Score of 58/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Trualt Bioenergy Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.